Analysis of clinical-biological features of adult acute lymphoblastic leukemia

作者：Diaz Ruiz Ro**iney; Aguilar Lopez Lilia; Vega Ruiz Arturo; Garces Ruiz Oscar; Nava Zavala Arnulfo; Rubio Jurado Benjamin^*

来源：Gaceta Medica de Mexico, 2015, 151(2): 150-156.

• Acute leukemia
• Acute lymphoblastic leukemia
• Leukemia

Introducction: Acute lymphoblastic leukemia (ALL) is a clonal disease characterized by a proliferation of immature cells. In immunophenotypic, cytogenetic and molecular studies, it is a heterogeneous disease with diverse manifestations and prognoses. The treatment is complex and is associated with complications during its course. Patients and Methods: A prospective study of cohort of patients with ALL. Subjects were recruited consecutively from April 2010 to November 2012 in the Specialties Hospital, IMSS. Results: We included 29 patients with ALL; of 16 females (55%) and 13 males (45%), 18 (64%) were treated with modified BFM, seven (25%) HiperCVAD, and three (11%) others. In all, 70% achieved complete remission, and 8.5% partial responses. Induction mortality in five patients (17%). Consolidation mortality in three (13%). Relapse 33%, with a mean of eight months (5-16 months), overall survival five months. At 26 months of follow-up, 13 patients (45%) maintained RC. Disease-free survival of 10 months and overall survival of 12 months was observed. Conclusion: The majority of patients, regardless of risk, reach complete remission. We found that the clinical and biological characteristics showed no significant differences related to the outcome. Immunochemotherapy treatment may improve response.

• 出版日期2015-4